Additional Quantitative & Qualitative Return for eRegulatory Enabled Research Sites Let’s be clear here. While the above is impactful – and necessary – for a proper evaluation of your future eRegulatory investment, many benefits don’t fit in a traditional ROI model. These qualitative measures of value are expressed in ways unique to each research site, but equally important, especially in terms of reviewing your investment over time. For example, a research site may ask questions like, how will this technology effect the culture of research at my organization? Will this technology expand our opportunities with experienced scientists and Principal Investigators? Will our research team benefit from adding more skills and, ultimately, be more satisfied at work? Below are some examples of qualitative results we’ve witnessed from the over 7,200 Research Sites using eBinders. Many of which have translated to the purely financial boost many organizations are seeking. Elimination of Binder Rooms With less paper-based processes, many of the organizations we’ve worked with have eliminated rooms dedicated entirely to binder and paper storage for both active and legacy studies. Many organizations leverage this freed up space by transforming it to various uses such as patient rooms, more space for teams to spread out and focus on essential tasks, and for housing specialized medical and scientific equipment required for precision medicine research. In addition, many of the large-scale multisite organizations we work with were using off-site secured storage for legacy studies. Just imagine what those costs per square foot would be in New York City, for example?
The ROI of an eRegulatory Platform
www.FlorenceHC.com © Florence Healthcare
Page 10 of 14
Made with FlippingBook Digital Proposal Creator